pubrio
Insilico Medicine

Insilico Medicine

United States · Biotechnology Research

Pharmaceuticals

Biotechnology

Information Technology

Biotechnology Research

Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.

Company Insights
Company Overview

2014

Founded

Biotechnology Research

Industry

United States

Location

1,016,253

Ranking

300 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Insilico Medicine

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​